{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:06:56Z","timestamp":1648796816042},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jdmv.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T02:46:48Z","timestamp":1506653208000},"page":"367-374","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Objectif tensionnel en 2017"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Yannoutsos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bura-Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Priollet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2017.08.003_bib0260","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(16)00002-7","article-title":"From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century","volume":"388","author":"Blacher","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jmv.2012.09.002","article-title":"Objective for 2015: 70\u00a0% of treated and controlled hypertensive patients. Seven key points to reach this goal in practice. A joint call for action of the French League Against Hypertension and the French Society of Hypertension","volume":"37","author":"Mourad","year":"2012","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0270","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147\u00a0randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0275","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61\u00a0prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/jhh.2009.34","article-title":"Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME study","volume":"24","author":"Blacher","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0285","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0295","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2011.1650","article-title":"Level of systolic blood pressure within the normal range and risk of recurrent stroke","volume":"306","author":"Ovbiagele","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0300","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0305","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.112.201400","article-title":"Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the Monica, risk, genetics, archiving, and monograph (MORGAM) project","volume":"60","author":"Vishram","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0310","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013\u00a0ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.113.01922","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the arguement","volume":"63","author":"Mancia","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/fcp.12044","article-title":"French Society of Hypertension. Management of hypertension in adults: the 2013\u00a0French Society of hypertension guidelines","volume":"28","author":"Blacher","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0325","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0330","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT study group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0335","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0340","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/HJH.0000000000000379","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels-overview and meta-analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0345","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80\u00a0years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0350","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00004872-200404000-00029","article-title":"Effects of immediate versus delayed antihypertensive therapy on outcome in the systolic hypertension in Europe trial","volume":"22","author":"Staessen","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0355","doi-asserted-by":"crossref","first-page":"d7541","DOI":"10.1136\/bmj.d7541","article-title":"Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to hypertension in the very elderly randomised controlled trial","volume":"344","author":"Beckett","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0360","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014\u00a0evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0365","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.115.06857","article-title":"Evidence to maintain the systolic blood pressure treatment threshold at 140\u00a0mmHg for stroke prevention: the northern Manhattan study","volume":"67","author":"Dong","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0370","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0375","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0380","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575\u00a0years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0385","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ancard.2014.05.013","article-title":"Orthostatic hypotension is associated with more severe hypertension in elderly autonomous diabetic patients from the french Gerodiab study at inclusion","volume":"63","author":"Bouhanick","year":"2014","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0390","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.115.07020","article-title":"An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society working group on the management of hypertension in very old, frail subjects","volume":"67","author":"Benetos","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0395","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/HYPERTENSIONAHA.116.07257","article-title":"Unattended blood pressure measurements in the systolic blood pressure intervention trial: implications for entry and achieved blood pressure values compared with other trials","volume":"67","author":"Kjeldsen","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0400","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0405","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00004872-200211000-00001","article-title":"Antihypertensive treatment in patients with type-2\u00a0diabetes mellitus: what guidance from recent controlled randomized trials?","volume":"20","author":"Zanchetti","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0410","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2\u00a0diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0415","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2\u00a0diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0420","first-page":"CD008277","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","volume":"10","author":"Arguedas","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0425","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2337\/dc12-0650","article-title":"Individualizing targets and tactics for high-risk patients with type 2\u00a0diabetes: practical lessons from ACCORD and other cardiovascular trials","volume":"35","author":"Riddle","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0430","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2\u00a0diabetes","volume":"359","author":"Paul","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0435","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(79)91274-1","article-title":"Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension","volume":"1","author":"Stewart","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0440","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(87)90231-5","article-title":"Benefits and potential harm of lowering high blood pressure","volume":"1","author":"Cruickshank","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0445","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.303.6799.385","article-title":"Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham study","volume":"303","author":"D\u2019Agostino","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1007856014581","article-title":"Antihypertensive treatment and the J-curve","volume":"14","author":"Cruickshank","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0455","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2015.02.038","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0460","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/08037051.2015.1106750","article-title":"No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: the VALUE trial","volume":"25","author":"Kjeldsen","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0465","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.22496","article-title":"Does achieving an intensive versus usual blood pressure level prevent stroke?","volume":"71","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0470","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ndt\/gft321","volume":"29","author":"Verbeke","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0475","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.116.303641","article-title":"Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal","volume":"116","author":"Zanchetti","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0480","series-title":"Prise en charge de l\u2019hypertension art\u00e9rielle de l\u2019adulte","article-title":"Recommandations de bonne pratique","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2016"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0485","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1152\/japplphysiol.90549.2008","article-title":"Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage","volume":"105","author":"Mitchell","year":"2008","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0490","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2015.10.084","article-title":"Pulse pressure and risk for cardiovascular events in patients with atherothrombosis: from the REACH registry","volume":"67","author":"Selvaraj","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0495","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/HYPERTENSIONAHA.114.04581","article-title":"Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham heart study","volume":"65","author":"Franklin","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0500","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Hemodynamic patterns of age-related changes in blood pressure. The Framingham heart study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0505","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.107.089797","article-title":"Diastolic blood pressure and mortality in the elderly with cardiovascular disease","volume":"50","author":"Protogerou","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2017.08.003_bib0510","first-page":"1044","article-title":"[Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic]","volume":"30","author":"Girerd","year":"2001","journal-title":"Presse Med"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451317302778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451317302778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T07:28:12Z","timestamp":1554103692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542451317302778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2542451317302778"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2017.08.003","relation":{},"ISSN":["2542-4513"],"issn-type":[{"value":"2542-4513","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Objectif tensionnel en 2017","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}